Oncology Pharma Inc. (ONPH)

Oncology Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2013	FY 2011	FY 2004	FY 2003	FY 2002
Period Ending	Aug 19, 2026	Mar 31, 2013	Jun 30, 2011	Mar 31, 2004	Mar 31, 2003	Mar 31, 2002
Last Close Price	0.05	1000000.00	10000000.00	12500000.00	52500000.00	325000000.00

Financial Efficiency

Fiscal Year	Current	FY 2013	FY 2011	FY 2004	FY 2003	FY 2002
Period Ending	Aug 19, 2026	Mar 31, 2013	Jun 30, 2011	Mar 31, 2004	Mar 31, 2003	Mar 31, 2002
Debt / Equity Ratio	-1.86	-1.86	-1.62	-0.14	-	-
Debt / FCF Ratio	555.27	555.27	-	-	-	-
Net Debt / Equity Ratio	-1.82	-1.82	-1.62	-0.10	-1.54	-1.24
Net Debt / EBITDA Ratio	-46.43	-46.43	-	-0.01	1.21	1.75
Net Debt / FCF Ratio	542.69	542.69	-	-0.01	0.85	1.66
Asset Turnover	-	-	-	1.31	1.22	0.84
Quick Ratio	0.04	0.04	-	0.12	1.73	2.42
Current Ratio	0.88	0.88	0.25	0.22	1.79	2.50
Return on Equity (ROE)	-	-	-	-447.14%	-93.71%	-64.37%
Return on Assets (ROA)	-	-	-	-118.19%	-35.06%	-28.79%
Return on Capital Employed (ROCE)	100.70%	100.70%	-14.70%	989.00%	-172.50%	-85.00%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2011

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error